The final host of plasmodium is ______ , however, the intermediate host of plasmodium is ______ .
The final host of plasmodium is ______ , however, the intermediate host of plasmodium is ______ .
Which<br/>one does it easily cause splenomegaly among the four plasmodiumspp.() A: Plasmodium<br/>vivax B: Plasmodium<br/>malariae C: Plasmodium<br/>falciparum D: Plasmodium ovale
Which<br/>one does it easily cause splenomegaly among the four plasmodiumspp.() A: Plasmodium<br/>vivax B: Plasmodium<br/>malariae C: Plasmodium<br/>falciparum D: Plasmodium ovale
Malaria is an infectious disease caused by infection of ( ) A: Ascaris lumbricoides B: Onchocerca volvlus C: Onchocerca cervicalis D: Plasmodium
Malaria is an infectious disease caused by infection of ( ) A: Ascaris lumbricoides B: Onchocerca volvlus C: Onchocerca cervicalis D: Plasmodium
Parasite which may be transmitted congenitally is ( ). A: Toxoplasma gondii B: Entamoeba histolytica C: Trichomonas vaginalis D: Plasmodium spp. E: Entamoeba coli
Parasite which may be transmitted congenitally is ( ). A: Toxoplasma gondii B: Entamoeba histolytica C: Trichomonas vaginalis D: Plasmodium spp. E: Entamoeba coli
寄生宿主和寄生部位最广泛的原虫是 A: Entamoeba histolytica B: Plasmodium vivax C: Leishmania donovani D: Trichomonas vaginalis E: Toxoplasma gondii
寄生宿主和寄生部位最广泛的原虫是 A: Entamoeba histolytica B: Plasmodium vivax C: Leishmania donovani D: Trichomonas vaginalis E: Toxoplasma gondii
人体可同时作为其中间宿主和终宿主的寄生虫是: A: Plasmodium vivax B: Taenia saginata C: Taenia solium D: Tocoplasma gondii E: Schistosema japonicum
人体可同时作为其中间宿主和终宿主的寄生虫是: A: Plasmodium vivax B: Taenia saginata C: Taenia solium D: Tocoplasma gondii E: Schistosema japonicum
人感染寄生虫能获得带虫免疫的是 A: A. Trichomonas vaginali:i B: B. Schi:ito:ioma japonicum C: C. Taenia :iaginata D: D. Brugia malayi E: E. Plasmodium falciparum
人感染寄生虫能获得带虫免疫的是 A: A. Trichomonas vaginali:i B: B. Schi:ito:ioma japonicum C: C. Taenia :iaginata D: D. Brugia malayi E: E. Plasmodium falciparum
请阅读以下文献，思考后回答下列问题：MoreiraLA,etal.AWolbachiaSymbiontinAedesaegyptiLimitsInfectionwithDengue,Chikungunya,andPlasmodiumCell2009;139(7):1268–781)在1269页左半页最下面一段,Thesemosquitostrainswerecomparedtotetracycline-treatedcounterpartsthatweregeneticallyidenticalbutlackedtheWolbachiainfection,namedPGYP1.tetandPGYP1.out.tet,respectively.用四环素处理得到的蚊作为Wolbachia阴性样本有何潜在问题？实验设计上可以做何改进？2)在1269页右半页第二段,ToprovideamoreconservativetestofWolbachia-mediatedinterference,mosquitoeswereintrathoracicallyinjectedwithDENV-2.Theseexperimentscircumventedthemidgutbarriertoinfection(Woodringetal.,1996)andallowedforthedeliveryofarepeatableinoculatingdose(around2,750infectiousparticles/mosquito)ofDENV-2thatproducedconsistenthigh-titerinfectionsincontrolmosquitoes.这种胸内直接注射的方法有何优点？有何潜在的问题？是否人为地将可能影响Dengue感染的因素排除在考虑之外？这些被排除考虑的因素可能有哪些？3)检测全身的总病毒量后，为何还要分部位检测病毒量？哪个检测指标跟疾病的传播更有相关性？4)文章中检测了免疫相关的基因表达，并提出Wolbachia可能通过激活免疫应答而影响Dengue,Chikungunya以及Plasmodium的传播。你认为这一假说是否合理？Wolbachia作为稳定存在于蚊体内的共生菌，是否可能被免疫系统识别？作为对比，转基因小鼠通常会对转基因表达的抗原产生免疫应答吗？
请阅读以下文献，思考后回答下列问题：MoreiraLA,etal.AWolbachiaSymbiontinAedesaegyptiLimitsInfectionwithDengue,Chikungunya,andPlasmodiumCell2009;139(7):1268–781)在1269页左半页最下面一段,Thesemosquitostrainswerecomparedtotetracycline-treatedcounterpartsthatweregeneticallyidenticalbutlackedtheWolbachiainfection,namedPGYP1.tetandPGYP1.out.tet,respectively.用四环素处理得到的蚊作为Wolbachia阴性样本有何潜在问题？实验设计上可以做何改进？2)在1269页右半页第二段,ToprovideamoreconservativetestofWolbachia-mediatedinterference,mosquitoeswereintrathoracicallyinjectedwithDENV-2.Theseexperimentscircumventedthemidgutbarriertoinfection(Woodringetal.,1996)andallowedforthedeliveryofarepeatableinoculatingdose(around2,750infectiousparticles/mosquito)ofDENV-2thatproducedconsistenthigh-titerinfectionsincontrolmosquitoes.这种胸内直接注射的方法有何优点？有何潜在的问题？是否人为地将可能影响Dengue感染的因素排除在考虑之外？这些被排除考虑的因素可能有哪些？3)检测全身的总病毒量后，为何还要分部位检测病毒量？哪个检测指标跟疾病的传播更有相关性？4)文章中检测了免疫相关的基因表达，并提出Wolbachia可能通过激活免疫应答而影响Dengue,Chikungunya以及Plasmodium的传播。你认为这一假说是否合理？Wolbachia作为稳定存在于蚊体内的共生菌，是否可能被免疫系统识别？作为对比，转基因小鼠通常会对转基因表达的抗原产生免疫应答吗？